Evaluation of safety and anti-obesity effects of DWP16001 in naturally obese dogs

BACKGROUND: The aim of this study was to investigate the anti-obesity effects of DWP16001, a sodium-glucose cotransporter-2 (SGLT2 inhibitor), in naturally obese dogs. A total of 20 dogs were divided into four equal groups: one obese control (OC group), and three treated groups; DWP0.2 group, DWP0.5...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Beomseok, Mahbubur, Rahman Md, Jin, Changfan, Choi, Ji-Soo, Lim, Hyun-Woo, Huh, Wan, Park, Joon Seok, Han, Jumi, Kim, Sokho, Lee, Youngwon, Park, Jinho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214997/
https://www.ncbi.nlm.nih.gov/pubmed/35733159
http://dx.doi.org/10.1186/s12917-022-03324-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214997/
https://www.ncbi.nlm.nih.gov/pubmed/35733159
http://dx.doi.org/10.1186/s12917-022-03324-2

Ejemplares similares